Theophylline Tablet, Extended Release
Product Images NDC 72789-442

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 72789-442). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789442 Label (72789442)

Theophylline Extended-Release Tablets, USP 450 mg, oral tablet, extended-release form. The label shows the product strength as 450 mg and indicates 100 tablets per container. Marketed and packaged by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, and manufactured by Strides Pharma Science Limited, Bengaluru, India. The label includes storage instructions and a barcode.*

FDA Label Image

Structure-theophylline (7487d300 1a59 4410 84ae 8a36b24b15a9 01)

Chemical structure of Theophylline, showing its molecular composition with carbon, nitrogen, oxygen, and hydrogen atoms arranged in a methylxanthine framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.